163 studies found for:    "Haemophilus influenzae"
Show Display Options
RSS Create an RSS feed from your search for:
"Haemophilus influenzae"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed
Has Results
Evaluation of Non-typable Haemophilus Influenzae and Pneumococcal Protein Vaccine Formulations in Young Adults
Conditions: Diseases Caused by Streptococcus Pneumoniae and Nontypable Haemophilus Influenzae;   Haemophilus Influenzae-Streptococcus Pneumoniae Vaccine
Interventions: Biological: GSK2231395A;   Biological: Engerix-B
2 Completed
Has Results
Safety of Hib-MenCY-TT Vaccine Versus Licensed Hib Conjugate Vaccine, Given at 2, 4, 6 and 12 to 15 Months of Age
Conditions: Neisseria Meningitidis-Haemophilus Influenzae Type b Vaccine;   Haemophilus Influenza Infections
Interventions: Biological: GSK Biologicals' Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine combined 792014;   Biological: ActHIB;   Biological: Pediarix/Infanrix Penta
3 Completed Safety and Reactogenicity of a Monovalent Conjugated Vaccine Against Haemophilus Influenzae Type b
Condition: Haemophilus Influenzae Type b
Intervention: Biological: Haemophilus influenzae type b
4 Completed Safety and Immunogenicity of a Monovalent Conjugated Vaccine Against Haemophilus Influenzae Type b
Condition: Haemophilus Influenzae Type b
Interventions: Biological: Haemophilus influenzae type b vaccine;   Biological: Commercial Haemophilus influenzae type b vaccine
5 Completed Study in Toddlers (12-18 Months) Comparing a Booster Dose of Vaxem Hib and Hiberix Vaccines for the Prevention of Haemophilus Influenzae Type b Infections in China
Condition: Haemophilus Influenzae Type b (Hib) Infection
Interventions: Biological: Vaxem Hib (Haemophilus influenzae type b (Hib) vaccine);   Biological: Hiberix (Haemophilus influenzae type b (Hib) vaccine)
6 Terminated Study to Assess the Safety of a New GSK Biologicals' GSK2231395A Candidate Vaccine
Conditions: Non-Typable H. Influenzae / S. Pneumoniae Infections;   Haemophilus Influenzae-Streptococcus Pneumoniae Vaccine
Interventions: Biological: GSK2231395A;   Biological: TwinrixTM
7 Completed
Has Results
Study of Quinvaxem for Vaccination Against Diphtheria, Pertussis, Tetanus, Hepatitis B and Diseases Caused by Haemophilus Influenzae Type B
Conditions: Diphtheria;   Pertussis;   Tetanus;   Hepatitis B;   Haemophilus Influenzae Infections
Intervention: Biological: Quinvaxem
8 Completed Nontypeable H. Influenzae in Healthy Adults
Condition: Haemophilus Influenzae (NTHI)
Intervention: Biological: NTHi Strain 2019
9 Completed
Has Results
Safety of Hib-MenCY-TT Vaccine Versus Licensed Hib Conjugate Vaccine, Given at 12 to 15 Months of Age.
Conditions: Meningococcal Infection;   Neisseria Meningitidis-Haemophilus Influenzae Type b Vaccine;   Haemophilus Influenza b Infections
Interventions: Biological: GSK Biologicals' Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine combined (792014);   Biological: PedvaxHIB;   Biological: Prevnar;   Biological: M-M-R II;   Biological: Varivax
10 Terminated Feasibility Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine in Healthy Infants at 3, 5 and 11 Months of Age.
Conditions: Haemophilus Influenzae Type b;   Poliomyelitis;   Hepatitis B;   Serogroup C Meningococcal Diseases;   Diphtheria;   Pertussis;   Diphtheria-Tetanus-aPertussis-Hepatitis B-Poliomyelitis-Haemophilus Influenzae Type b-Neisseria Meningitidis Vaccines;   Tetanus
Interventions: Biological: GSK2202083A vaccine;   Biological: Infanrix hexa;   Biological: Menjugate
11 Completed Safety of Haemophilus Influenza Type b Vaccine When Administered to Korean Children
Condition: Haemophilus Influenzae Type B Infection
Intervention: Biological: Haemophilus influenza type b conjugate vaccine
12 Completed Study in Infants (6-12 Months) Comparing Two Doses of a Monovalent Glycoprotein-Conjugated (Diptheria Toxin -CRM197) Vaccine Versus a Tetanus Toxoid-Conjugated Vaccine Available for the Prevention of Haemophilus Influenzae Type b Infections in China
Condition: Haemophilus Influenzae Type b (Hib) Infection
Intervention: Biological: Haemophilus influenzae type b (Hib) vaccine
13 Completed Study to Compare Pediacel® to Infanrix®-IPV+Hib When Both Are Co-Administered With Prevenar® in Infants and Toddlers
Conditions: Diphtheria;   Tetanus;   Pertussis;   Poliomyelitis;   Haemophilus Influenzae Type b
Interventions: Biological: PEDIACEL® and Prevenar®;   Biological: Infanrix®-IPV+Hib and Prevenar®
14 Completed Study to Eliminate Hib Carriage in Rural Alaska Native Villages
Conditions: Haemophilus Influenzae Type B;   Carrier State
Intervention: Biological: Hib conjugate vaccine (HbOC, Wyeth Vaccines)
15 Completed Comparison of Safety and Immunogenicity of Pediacel™ and Infanrix™ IPV+Hib (Penta) Given in a 3 Dose Schedule in Infants
Conditions: Pertussis;   Diphtheria;   Tetanus;   Poliomyelitis;   Haemophilus Influenzae Type b
Interventions: Biological: DT5aP-IPV-Hib 5-component Pertussis vaccine;   Biological: Infanrix® -IPV+Hib
16 Completed
Has Results
Study of Modified Process Hib/Hep B Vaccine in Infants (V121-019)(COMPLETED)
Conditions: Haemophilus Influenzae Type B;   Hepatitis B
Interventions: Biological: Comparator: Modified Process Vaccine;   Biological: Comparator: COMVAX™
17 Completed
Has Results
Safety and Immunogenicity Study of Hib-MenCY-TT Vaccine Compared to Licensed Hib Conjugate Vaccine
Conditions: Meningococcal Infection;   Haemophilus Influenzae Type b Infection
Interventions: Biological: GSK Biologicals' Haemophilus influenzae type b and Neisseria meningitidis 792014 vaccine;   Biological: ActHIB;   Biological: PedvaxHIB;   Biological: Pediarix;   Biological: Prevnar;   Biological: M-M-R II;   Biological: Varivax
18 Completed Immunogenicity and Safety Study of LBVH0101 in Healthy Infants at Two, Four and Six Months of Age
Condition: Infectious Disease by Haemophilus Influenzae Type b
Interventions: Biological: LBVH0101 (Hib vaccine);   Biological: Hiberix™ Vaccine
19 Active, not recruiting Database Surveillance Safety Study of PENTACEL® Vaccine
Conditions: Diphtheria;   Tetanus;   Pertussis;   Haemophilus Influenzae
Interventions: Biological: DTaP-IPV/Hib;   Biological: Other DTap Vaccines
20 Completed
Has Results
Study of the DTaP-IPV-Hep B-PRP~T Combined Vaccine Following a Primary Series of DTacP IPV-HepB-PRP-T or Infanrix Hexa™
Conditions: Diphtheria;   Tetanus;   Pertussis;   Hepatitis B;   Poliomyelitis;   Haemophilus Influenzae Type B Infection
Interventions: Biological: DTaP-IPV-Hep B-PRP~T vaccine (Batch 1);   Biological: DTaP-IPV-Hep B-PRP~T vaccine (Batch 2);   Biological: DTaP-IPV-Hep B-PRP~T vaccine (Batch 3);   Biological: Infanrix Hexa™

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years